Why write ten lines of code when one will do? From magic variable swaps to high-speed data counting, these Python snippets ...

This is a review of Truth: What It Is, How To Find It & Why It Still Matters. by Michael Shermer, forthcoming from Johns Hopkins University Press. Amidst claims of “fake news,” “alternative facts,” ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Getting a handle on LeetCode can feel like a big task, especially when you’re starting out. But with the right approach and tools, it becomes much more manageable. Python, with its clear syntax and ...

Plastics are woven into every aspect of our lives, but what was once the poster child for convenience is fast becoming a pariah product. The era of single-use plastic must end; banning it is the only ...

Sometimes, reading Python code just isn’t enough to see what’s really going on. You can stare at lines for hours and still miss how variables change, or why a bug keeps popping up. That’s where a ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. This was largely due to news from a ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...